Dr. Rana McKay

Like the testicular atrophy that could potentially happen, you know, hair loss, you know, changes in even smell, you know, the different kinds of things that can happen when patients are on treatment. I think it's important to go through that. You know, the other thing is the bone health.

Like the testicular atrophy that could potentially happen, you know, hair loss, you know, changes in even smell, you know, the different kinds of things that can happen when patients are on treatment. I think it's important to go through that. You know, the other thing is the bone health.

Like the testicular atrophy that could potentially happen, you know, hair loss, you know, changes in even smell, you know, the different kinds of things that can happen when patients are on treatment. I think it's important to go through that. You know, the other thing is the bone health.

Some patients might need a baseline DEXA scan if they're certainly if they're going to be on treatment for a prolonged period of time.

Some patients might need a baseline DEXA scan if they're certainly if they're going to be on treatment for a prolonged period of time.

Some patients might need a baseline DEXA scan if they're certainly if they're going to be on treatment for a prolonged period of time.

and optimization around bone health, muscular loss, mood, you know, irritable mood, sleep, metabolic changes is critically important, you know, and some and actually even thinking about doing a cardiovascular risk assessment or make sure somebody is doing that, whether it be their internist, cardiologist or you yourself as their oncologic care provider. is important.

and optimization around bone health, muscular loss, mood, you know, irritable mood, sleep, metabolic changes is critically important, you know, and some and actually even thinking about doing a cardiovascular risk assessment or make sure somebody is doing that, whether it be their internist, cardiologist or you yourself as their oncologic care provider. is important.

and optimization around bone health, muscular loss, mood, you know, irritable mood, sleep, metabolic changes is critically important, you know, and some and actually even thinking about doing a cardiovascular risk assessment or make sure somebody is doing that, whether it be their internist, cardiologist or you yourself as their oncologic care provider. is important.

So I think kind of, I think it's key to go through that. I think this is also an opportunity where our nursing team can be leveraged, our APP team can be leveraged. You know, they're really fantastic and kind of going through the detailed summaries of the different things that patients may experience.

So I think kind of, I think it's key to go through that. I think this is also an opportunity where our nursing team can be leveraged, our APP team can be leveraged. You know, they're really fantastic and kind of going through the detailed summaries of the different things that patients may experience.

So I think kind of, I think it's key to go through that. I think this is also an opportunity where our nursing team can be leveraged, our APP team can be leveraged. You know, they're really fantastic and kind of going through the detailed summaries of the different things that patients may experience.

Yeah, you know, I think the big take home message is that, you know, you can't just like put somebody on their ADT and check out because what we saw from the PRONOUNCE study, which was actually designed to look at cardiovascular risk in people that were getting an agonist versus an antagonist. And in the context of the trial, they had very robust upfront cardiovascular risk assessment.

Yeah, you know, I think the big take home message is that, you know, you can't just like put somebody on their ADT and check out because what we saw from the PRONOUNCE study, which was actually designed to look at cardiovascular risk in people that were getting an agonist versus an antagonist. And in the context of the trial, they had very robust upfront cardiovascular risk assessment.

Yeah, you know, I think the big take home message is that, you know, you can't just like put somebody on their ADT and check out because what we saw from the PRONOUNCE study, which was actually designed to look at cardiovascular risk in people that were getting an agonist versus an antagonist. And in the context of the trial, they had very robust upfront cardiovascular risk assessment.

Patients on both arms were getting seen by cardiology or, you know, kind of getting ongoing kind of cardio prevention. And at the end of the day, the study had to close down because that rate was so low and in both arms and wasn't any different in either arm. So I think the key take home is Like prevention is key and staying on top of it is key.

Patients on both arms were getting seen by cardiology or, you know, kind of getting ongoing kind of cardio prevention. And at the end of the day, the study had to close down because that rate was so low and in both arms and wasn't any different in either arm. So I think the key take home is Like prevention is key and staying on top of it is key.

Patients on both arms were getting seen by cardiology or, you know, kind of getting ongoing kind of cardio prevention. And at the end of the day, the study had to close down because that rate was so low and in both arms and wasn't any different in either arm. So I think the key take home is Like prevention is key and staying on top of it is key.

Now, I think, you know, certainly if I have somebody before me who's got an extensive cardiac history and they really need to be on ADT, they've got high risk disease and you're treating them with a curative intent and they need to start treatment. Like, yeah, in that context, I'm going to go ahead and prescribe medication.

Now, I think, you know, certainly if I have somebody before me who's got an extensive cardiac history and they really need to be on ADT, they've got high risk disease and you're treating them with a curative intent and they need to start treatment. Like, yeah, in that context, I'm going to go ahead and prescribe medication.